PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Firas Hatoum

Moffitt Cancer Center

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · JOURNAL ARTICLE

A phase II study assessing the feasibility and clinical efficacy of adaptive immunotherapy combination with VEGFR-TKI in patients with advanced renal cell carcinoma

Future Oncology

Phase II feasibility and safety study of an adaptive immunotherapy-TKI combination in advanced RCC; early-stage design testing a novel treatment approach with surrogate endpoints rather than hard clinical outcomes.

PreliminaryBrandon Dyer Jazlyn Heiligh Jad Chahoud

Study details

DesignPhase II feasibility trial

InterventionAdaptive immunotherapy combination therapy…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support